Literature DB >> 32250429

Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease-First, Do No Harm.

Emilie P Belley-Cote1,2, John W Eikelboom1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32250429     DOI： 10.1001/jamanetworkopen.2020.2237

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  3 in total

Review 1.  A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease.

Authors:  Kathrine Parker; John Hartemink; Ananya Saha; Roshni Mitra; Penny Lewis; Albert Power; Satarupa Choudhuri; Sandip Mitra; Jecko Thachil
Journal:  J Nephrol       Date:  2022-08-25       Impact factor: 4.393

2.  Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort.

Authors:  John Sy; Jiu-Ting Hsiung; Drake Edgett; Kamyar Kalantar-Zadeh; Elani Streja; Wei Ling Lau
Journal:  Am J Nephrol       Date:  2021-03-31       Impact factor: 3.754

Review 3.  Multitargeted interventions to reduce dialysis-induced systemic stress.

Authors:  Bernard Canaud; Melanie P Stephens; Milind Nikam; Michael Etter; Allan Collins
Journal:  Clin Kidney J       Date:  2021-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.